Smooth Drug Development December 2020 News Release
Published on Saturday January 02, 2021
New contracts were signed in December: • A contract for submission of the final report to the Ministry of Health of the Russian Federation. • Medical writing agreement with our long-term Sponsor.
Smooth Drug Development November 2020 News Release
Published on Thursday December 03, 2020
New projects started in November: • Bioequivalence trial (INN: Azacitidine). • Medical writing project (INN: Amtolmetin guacil).
Smooth Drug Development October 2020 News Release
Published on Tuesday November 03, 2020
We were working on the following new projects in October: • We signed a contract for data management and medical writing project of clinical study in Russia.
Smooth Drug Development September 2020 News Release
Published on Tuesday October 06, 2020
We were working on the following new projects in September: • Observational trial is being initiated in dermatology • We signed a contract for a bioequivalence study (INN: Paracetamol) with long-term sponsor
Smooth Drug Development August 2020 News Release
Published on Sunday September 06, 2020
We were working on the following new projects in August: • We are in the process of final negotiation of the contract for a BE study with a Czech company
Smooth Drug Development July 2020 News Release
Published on Thursday August 06, 2020
We were working on the following new projects in July: • Our company signed a contract for a BE study (INN: Drotaverine) from a big Russian pharma • We finalized a contract for III phase study in patients with arthrosis • We won a tender performed by a leading Russian vaccine company for full services projects
Smooth Drug Development June 2020 News Release
Published on Tuesday July 07, 2020
The projects are moving regardless the pandemic situation:Nimesulide phase II study data base is lockedCTA was performed in our phase II study in COVID-19, SIVs are performedLast patient last visit was performed in our phase III PID study in childrenCSR in etoricoxib trial was submitted to MoHDysmenorrhoea pain phase III study is initiatedClinical part in schizophrenia phase III is close to an endClose out visit was performed in Erlotinib trial
Approach to clinical trials during pandemic COVID-19
Published on Wednesday July 01, 2020
Measures to promote patients safety during COVID-19 pandemic include: Direct to patients shipment of investigational drug
Smooth Drug Development May 2020 News Release
Published on Saturday June 06, 2020
We were working on the following new projects in May: Smooth Drug Development signed several contracts for medical writing
March news on Smooth Drug Development
Published on Monday April 06, 2020
Smooth Drug Development is happy to share its March news
Smooth Drug Development work during COVID-19
Published on Monday March 23, 2020
COVID-19; Smooth Drug Development
Smooth Drug Development January and February 2020 News Release
Published on Sunday March 01, 2020
Smooth Drug Development clinical trials in January and February 2020
Smooth Drug Development November 2019 News Release
Published on Saturday November 30, 2019
Smooth Drug Development clinical trials in November
Smooth Drug Development October 2019 News Release
Published on Friday November 01, 2019
Clinical and Regulatory Operations Department of Smooth Drug Development reached several milestones in our current projects:Our clinical team started the clinical part in a bioequivalence trial with etoricoxib
Smooth Drug Development September 2019 News Release
Published on Wednesday October 02, 2019
Smooth Drug Development is happy to share its September news